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Abstract 
The exosome is a conserved multi-subunit ribonuclease complex that functions in 3' 
end processing, turnover and surveillance of nuclear and cytoplasmic RNAs. In the 
yeast nucleus, the 10-subunit core complex of the exosome (Exo-10) physically and 
functionally interacts with the Rrp6 exoribonuclease and its associated cofactor Rrp47, 
the helicase Mtr4 and the exosome cofactor Mpp6. Here we show that binding of 
Mtr4 to Exo-10 in vitro is dependent upon both Rrp6 and Rrp47, whereas Mpp6 binds 
directly and independently of other cofactors. Crystallographic analyses reveal that 
the N-terminal domains of Rrp6 and Rrp47 form a highly intertwined structural unit. 
Rrp6 and Rrp47 synergize to create a composite and conserved surface groove that 
binds the N-terminus of Mtr4. Mutation of conserved residues within Rrp6 and Mtr4 
at the structural interface disrupt their interaction and inhibit growth of strains 
expressing a C-terminal GFP fusion of Mtr4. These studies provide detailed structural 
insight into the interaction between the Rrp6 - Rrp47 complex and Mtr4 that mediates 
an important link between Mtr4 and the core exosome.  
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Introduction 
Most cellular ribonucleic acids are transcribed in the nucleus as larger precursor 
molecules that are then processed to produce mature, functional RNAs. The 
maturation of ribosomal RNAs (rRNAs), small nuclear and nucleolar RNAs (snRNAs 
and snoRNAs) requires the trimming of the extended 3' end of their nascent 
transcripts and the elimination of the excised RNA fragments (reviewed in Bernstein 
& Toth, 2012). These processes involve a complex of ribonucleases known as the 
RNA exosome (Allmang et al, 1999a). In addition to 3' end processing, the exosome 
functions in RNA turnover and surveillance pathways (reviewed in Schmid & Jensen, 
2008; Schaeffer et al, 2011; Chlebowski et al, 2013). In the nucleus, it mediates the 
turnover of precursor transfer RNAs (pre-tRNAs) and precursor messenger RNAs 
(pre-mRNAs) (Gudipati et al, 2012). The nuclear exosome also swiftly eliminates 
misprocessed tRNAs (Kadaba et al, 2004) and pre-mRNAs (Bousquet-Antonelli et al, 
2000; Hilleren et al, 2001) as well as cryptic unstable transcripts (CUTs) generated by 
antisense and intergenic transcription (Wyers et al, 2005; Davis & Ares, 2006; Neil et 
al, 2009). In the cytoplasm, the exosome participates in the turnover of mature 
mRNAs (Anderson & Parker, 1998) and in quality-control pathways that eliminate 
defective mRNAs with premature stop codons (Mitchell & Tollervey, 2003) or 
without a stop codon (van Hoof et al, 2002). 
 The exosome core complex consists of ten subunits that are evolutionarily 
conserved and are essential in yeast (Allmang et al, 1999b). Nine of these subunits 
form a catalytically inactive barrel-like structure (Exo-9) (Liu et al, 2006; 
Dziembowski et al, 2007) that threads RNA substrates to the tenth subunit, Rrp44 
(also known as Dis3) (Bonneau et al, 2009; Malet et al, 2010; Wasmuth & Lima, 
2012; Makino et al, 2013a; Liu et al, 2014). Rrp44 is bound at the bottom of the Exo-
 4
9 barrel and contains a processive 3'-5'-exoribonuclease site and an endonuclease site 
(reviewed in Schneider & Tollervey, 2013; Makino et al, 2013b). While the Exo-10 
core is found in both the nucleus and the cytoplasm, physical and genetic interactions 
have linked the exosome core to several cofactors that have specific subcellular 
localization (reviewed in Schneider & Tollervey, 2013). In the cytoplasm, the 
exosome functions together with the Ski complex, a multi-subunit assembly centered 
at the helicase Ski2 (Anderson & Parker, 1998; Araki et al, 2001; Halbach et al, 
2013). In the yeast nucleus, the exosome is associated with a set of conserved proteins 
that include Rrp6 (known as PM/Scl-100 in humans), Rrp47 (also known as Lrp1 in 
yeast and as C1D in humans), Mpp6 and Mtr4 (also known as Dob1 in yeast) 
(reviewed in Butler & Mitchell, 2011). 
 Rrp6 contains a 3'-5'-exoribonuclease site. In contrast to Rrp44, the Rrp6 
nuclease functions in a distributive manner and stalls when encountering structured 
RNA sequences (Briggs et al, 1998; Burkard & Butler, 2000; Liu et al, 2006; 
Januszyk et al, 2011). Rrp6 binds the exosome directly, near the top of the Exo-9 
barrel (Cristodero et al, 2008; Makino et al, 2013a; Wasmuth et al, 2014). Although 
in vitro Rrp6 and Rrp44 can bind Exo-9 independently of each other, Exo-9 binding 
interconnects the enzymatic properties of the two ribonucleases (Liu et al, 2006; 
Wasmuth & Lima, 2012). The interplay between Rrp6 and Rrp44 also emerges from 
in vivo studies. During the maturation of 5.8S rRNA, Rrp44 degrades the 3' end of the 
precursor to leave a processing intermediate that is then trimmed to the final product 
by Rrp6. This intermediate features a 3' extension of 30 nucleotides (Briggs et al, 
1998), a length that corresponds to the size of the internal channel of Exo-10 
(Bonneau et al, 2009; Makino et al, 2013a). Rrp6 can carry out the last processing 
step even when separated from Exo-10 (Callahan & Butler, 2008). 
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 Rrp47 and Rrp6 interact in vitro (Stead et al, 2007) and in vivo (Mitchell et al, 
2003; Synowsky et al, 2009). Consistently, depletion of Rrp47 leads to defects in 
RNA processing and degradation that are similar to those observed in rrp6Δ strains 
(Mitchell et al, 2003; Peng et al, 2003). The presence of Rrp6 protects Rrp47 from 
degradation in yeast and conversely Rrp47 stabilizes Rrp6 (Stuparevic et al, 2013; 
Feigenbutz et al, 2013b; 2013a). Knockout of either Rrp6 or Rrp47 is synthetically 
lethal with the absence of Mpp6, another factor that functions in the maturation of 
5.8S rRNA, the degradation of CUTs and pre-mRNA surveillance (Milligan et al, 
2008). The human orthologue of Mpp6 has been shown to interact with PM-Scl100 –
 C1D (Rrp6 – Rrp47) in co-immunoprecipitation experiments, and also with human 
Mtr4 (Schilders et al, 2007). Mtr4 is a Ski2-related RNA helicase (Jackson et al, 
2010; Weir et al, 2010; Halbach et al, 2012) and is essential for viability in yeast (la 
Cruz et al, 1998). Mtr4 is required for Rrp6-dependent and Rrp6-independent 
functions of the nuclear exosome (Jackson et al, 2010; Klauer & van Hoof, 2013) and 
is also part of the TRAMP complex (LaCava et al, 2005; Wyers et al, 2005; 
Vanacova et al, 2005). In human cells, Mtr4 has been shown to associate with either 
Mpp6 (Schilders et al, 2007) or Rrp6 (Lubas et al, 2011). In yeast, all genetic data 
suggest a close association between Mtr4 and the exosome but no direct interaction 
has been reported thus far. In this work, we dissected the interaction network of the 
nuclear cofactors of the yeast exosome in vitro and identified the structural basis for 
how Rrp6 and Rrp47 assemble in a complex that directly recruits Mtr4. 
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Results 
 
S. cerevisiae Rrp6 – Rrp47 recruits Mtr4 to the exosome  
The domain organization of nuclear cofactors of the S. cerevisiae exosome is in 
several cases known from previous structural studies or can be extrapolated from 
sequence analysis (Fig 1A). The Rrp6 exoribonuclease is a modular protein of 733 
residues. The Rrp6 N-terminal region (so-called PMC2NT) mediates the interaction 
with Rrp47 and is expected to be a folded domain (Stead et al, 2007). The central 
region encompasses the exoribonuclease (Exo domain), which includes the catalytic 
DEDD site and the regulatory HRDC domain (Midtgaard et al, 2006). The C-terminal 
region consists of mainly low-complexity sequences and contains both the Exo-9-
binding segment and two nuclear localization signals (NLSs) (Callahan & Butler, 
2008; Makino et al, 2013a). Rrp47 (184 residues) has an N-terminal domain that 
binds Rrp6 and a C-terminal low-complexity region rich in positively charged 
residues (Costello et al, 2011) (Fig 1A). The Mtr4 helicase (1073 residues) contains a 
low-complexity N-terminal region of 80 residues followed by a DExH helicase core 
characterized by an insertion domain also known as the arch domain (Weir et al, 
2010; Jackson et al, 2010) (Fig 1A). Mpp6 (186 residues) is a small basic protein 
without recognizable domains. 
 We recombinantly expressed and purified different versions of these proteins, 
incubated them in different combinations and analyzed the mixtures using size-
exclusion chromatography to dissect their direct interactions (Fig 1B-1G). In the case 
of Rrp6, we engineered a version of the protein that spans from the Rrp47-binding 
domain to the exosome-binding domain (Rrp6ΔNLS), as the inclusion of the very C-
terminus resulted in an unstable sample that was quickly degraded. Rrp6ΔNLS co-
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eluted with full-length Rrp47 (Fig 1B, peak 1 in the size exclusion chromatography 
profile on the left and lane 1 in the corresponding Coomassie gel on the right). 
Rrp6ΔNLS – Rrp47 did not interact with Mpp6 (Fig 1B, peaks and lanes 2 and 3). 
Instead, Rrp6ΔNLS – Rrp47 interacted with full-length Mtr4 (Fig 1B, peak and lane 2). 
Interestingly, Mtr4 required the Rrp6ΔNLS – Rrp47 complex to bind to Exo-9 (Fig 1C, 
compare peak and lane 1, with peaks and lanes 4 and 5). Rrp6 lacking the N-terminal 
Rrp47-binding domain (Rrp6ΔN) co-eluted with Exo-9 but lost most of the binding to 
Mtr4 (Fig 1C, peaks and lanes 5 and 6). The other nuclear exosome cofactor, Mpp6, 
interacted with Exo-9 both in the presence and in the absence of Rrp6ΔNLS – Rrp47 
(Fig 1D, peak and lane 1, compare with peak and lane 2). Finally, Exo-9, Rrp6ΔNLS, 
Rrp47, Mtr4, Mpp6 and Rrp44 co-eluted in a single peak that corresponds to the 14-
subunit nuclear exosome (Fig 1D, peak and lane 6). These data indicate that 
S. cerevisiae Rrp6, Rrp44 and Mpp6 can bind directly, independently and 
concomitantly to Exo-9, while Mtr4 is recruited to the exosome mainly by binding to 
Rrp6 – Rrp47.  
 
The N-terminal domains of Mtr4, Rrp6 and Rrp47 form a ternary complex in 
vitro 
Consistent with previous studies (Stead et al, 2007; Costello et al, 2011; Dedic et al, 
2014), we observed an interaction between the N-terminal regions of Rrp6 (Rrp6N, 
residues 1-111) and Rrp47 (Rrp47∆C, residues 1-133) (Fig. 1A). Rrp6N and Rrp47ΔC 
co-eluted with Mtr4 in size-exclusion assays (Fig 1E, peak and lane 1). Next, we 
assessed which part of Mtr4 is recognized by Rrp6 – Rrp47. Rrp6N and Rrp47ΔC co-
eluted with the N-terminal region of Mtr4 (Mtr480) (Fig 1F, lane and peak 1), while no 
interaction was detected with the helicase domain (Mtr4Δ80) (Fig 1E, peaks and lanes 
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4 and 5). In isolation, neither Rrp6N nor Rrp47ΔC interacted with Mtr4 (Fig 1G, peaks 
and lanes 1, 2 and 3, 4, respectively), suggesting that both proteins are required for 
binding. Finally, the interaction is conserved across species, as the S. cerevisiae 
Rrp6N – Rrp47ΔC complex formed a complex with the N. crassa Mtr4 orthologue, 
FRH (Fig E1A). Sequence analysis showed that only the first 20 residues of the N-
terminal region of Mtr4 are evolutionarily conserved (Fig 4C). Rrp6N – Rrp47ΔC 
indeed formed a ternary complex with an Mtr41-20 peptide (Mtr4N) (Fig E1B). As a 
note, the cytoplasmic Ski2 helicase does not contain an analogous N-terminal 
sequence, and consistently the cytoplasmic exosome complex does not contain Rrp6 
and Rrp47. Finally, using limited proteolysis experiments we could narrow down the 
Rrp6-binding domain of Rrp47 even further to residues 1-103 (Rrp47N) (Fig E1C and 
Fig 1A). 
 
Structure determination of the Rrp6N - Rrp47N - Mtr4N complex 
Alone, Rrp47ΔC eluted as an apparent oligomer in size exclusion chromatography (Fig 
1G, peak 4), consistent with previous reports of its oligomeric nature when in 
isolation (Feigenbutz et al, 2013b). Upon co-expression, however, the Rrp6N –
 Rrp47ΔC complex eluted with a predominant peak corresponding to the expected 
molecular weight of a 1:1 complex (Fig 1G, peak 5). Rrp6N – Rrp47ΔC crystallized in 
a tetragonal space group with three independent binary complexes in the asymmetric 
unit (Fig E2A). The structure was determined by combining phases from single-
wavelength anomalous dispersion (SAD) experiments using crystals containing 
tantalum bromide and crystals of selenomethionine-substituted protein. The model 
has been refined to 2.64 Å resolution with an Rfree of 23.8%, Rfactor of 20.7% and 
good stereochemistry (Table I). 
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 Based on the atomic model of the binary Rrp6N – Rrp47ΔC complex (Fig 2A) 
and on the limited proteolysis experiments (Fig E1C), we trimmed the C-terminus of 
Rrp47 further and crystallized a ternary complex of Rrp6N, Rrp47N and Mtr4N. 
Rrp6N – Rrp47N – Mtr4N crystallized in a merohedrally-twinned trigonal space group 
with three independent copies of the complex in the asymmetric unit (Fig E2B). The 
structure was determined by molecular replacement using the coordinates of Rrp6N –
 Rrp47ΔC in combination with anomalous dispersion from yttrium ions that were 
required for crystallization and mediated lattice contacts. The model has been refined 
to 2.4 Å resolution with an Rfree of 23.9%, Rfactor of 19.4% and good geometry 
(Table I). The atomic models of Rrp6 and Rrp47 are very similar in the three ternary 
complexes in the asymmetric unit, and are also very similar when compared to the 
structure of the binary complex (root mean square deviation rmsd of 1.26 Å over 182 
α-carbon atoms). The main difference is that in one of the three copies of Rrp6N -
Rrp47ΔC, twenty more residues of the C-terminal helix of Rrp47 are well ordered as a 
result of lattice contacts with a symmetry related molecule (compare Fig 2A and Fig 
2B, left panel). The atomic model of Mtr4 shows well-defined electron density from 
residue 4 up to residue 17 (Fig 2B and Fig E2C). 
 
The Rrp6 – Rrp47 interaction: an intertwined structure 
The Rrp6N – Rrp47N complex has a compact α-helical fold (Fig 2B). At the secondary 
structure level, Rrp6N and Rrp47N are remarkably similar. They both consist of three 
long α-helices (α1, α2 and α3) with a short α-helix (αshort) between α1 and α2. The 
stretch of Rrp6N encompassing the first helix-turn-helix (α1–αshort–α2) can be 
superposed to the equivalent stretch of Rrp47N (rmsd of 2.06Å over 39 Cα atoms) 
(Fig 2C). The main topological difference between the two proteins is that helix α3 is 
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oriented antiparallel to α2 in the case of Rrp47N, while it points in the opposite 
direction in the case of Rrp6N (Fig 2C and topology in Fig 2D). 
 The secondary structure elements of Rrp6N and Rrp47N are highly intertwined 
(Fig 2B and 2D). The first helix-turn-helix of Rrp6N interdigitates with the first helix-
turn-helix of Rrp47N, forming a heterodimeric 4-helix bundle (Fig 2D and 3A). The 
α3 helices of Rrp6N and Rrp47N pack against the side of the bundle that is lined by the 
α2 helices (Fig 2D and 3B). Evolutionarily conserved residues of the α1 and α2 
helices form an extensive hydrophobic core in the center of the bundle (Fig 3A, 4A 
and 4B). The interactions between the α2 and α3 helices are also extensive, apolar 
and conserved (Fig 3B, 4A and 4B). The interaction of Rrp6N with Rrp47N buries 
5460 Å2 (i.e. more than 33%) of the surface area of the two proteins. The complex 
appears to be further stabilized by inter-molecular salt-bridges present on the outer 
surface of the heterodimer. Finally, the structure of the binary complex shows that the 
C-terminal helix of Rrp47 protrudes out of the globular core of Rrp6N – Rrp47ΔC, 
extending about 30 Å into the solvent (Fig 2A). The C-terminal region of Rrp47 that 
has been reported to interact with proteins involved in snoRNP assembly (Costello et 
al, 2011) would likely extend even further.  
 
Mtr4 binds Rrp6 – Rrp47 via evolutionarily conserved interactions  
The overall structure of Rrp6N – Rrp47N resembles a turn of a superhelix with a 
conserved concave surface that is formed by the α1 helix of Rrp6 and the α2 and α3 
helices of Rrp47 and that provides the binding site for Mtr4N (Fig 2B and 5A). Mtr4N 
binds as a short α-helix (residues 6-11), with extended segments at both ends. Apolar 
residues of Mtr4 (Leu6, Phe7, Val9, Phe10, Val 15 and Leu17) contact hydrophobic 
residues of Rrp6 (Leu10, Ile14 and Val17) and Rrp47 (Tyr10, Tyr55, Phe62, Leu77, 
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Leu80 and Met87) (Fig 5B). In addition, Mtr4 Glu12 forms a salt bridge with Rrp6 
Arg18, while Mtr4 Asp5 and Glu16 interact electrostatically with Lys84 and Lys6 of 
Rrp47 respectively. We tested the effect of mutating a set of the conserved interacting 
residues in in vitro binding assays. Isothermal titration calorimetry (ITC) experiments 
showed that Rrp6N – Rrp47ΔC bound to the Mtr4N peptide with a Kd of 1.3 μM, but no 
binding to an Mtr4N F7A, F10A mutant was detected (Fig 5C, left and central panel). 
Conversely, an Rrp6N I14E, R18E – Rrp47ΔC mutant showed no binding to wild-type 
Mtr4N by ITC (Fig 5C, right panel). We note that there are also additional conserved 
residues, including Asp27 and Phe30 in the Rrp6 αshort helix and Rrp6 Glu90 and 
Asp97 on the convex surface of the superhelix (Fig. 5A). These residues do not 
contact Mtr4N in the structure and consistently their mutation did not affect binding to 
Mtr4N in ITC experiments (Fig E3A). 
 
Impact of Rrp6N-Rrp47ΔC on RNA binding and degradation 
The concave surface of Rrp6N – Rrp47N that binds Mtr4N is highly positively charged 
(Fig 6A). Given these electrostatic properties and previous reports that Rrp47 binds 
RNA (Stead et al, 2007), we tested whether the interaction between Rrp6 and Rrp47 
might also serve as an RNA-binding site (at least in the absence of Mtr4). Since from 
the structure of the N-terminal region of Rrp6 is expected to be unfolded in the 
absence of Rrp47, we compared Rrp61-518 – Rrp47ΔC with Rrp6122-518. We measured 
RNA-binding affinities by fluorescence anisotropy using fluorescein-labeled 
poly(A)35 or poly(U)30 RNAs and using a catalytic mutant of Rrp6 (Asp296 to Asn). 
In these experiments, we did not detect RNA binding to Rrp6N – Rrp47ΔC (Fig 6B), 
suggesting its positively charged concave surface is a protein-protein interaction site 
for Mtr4N rather than an RNA-binding site. Rrp6122-518, D296A and Rrp61-518, D296A –
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 Rrp47ΔC bound RNA with a similar affinity in the low micromolar range (Fig 6B). In 
RNA degradation assays, the Rrp61-518 – Rrp47ΔC complex showed somewhat lower 
activity as compared to that of Rrp6122-518 (Fig 6C), indicating that the Rrp6N-Rrp47ΔC 
module subtly downregulates the enzymatic properties of the Rrp6 ribonuclease. 
Although the rationale for this effect is currently unclear, similar observations have 
been recently reported (Dedic et al, 2014; Barbosa et al, 2014).  
We carried out a set of degradation assays of Rrp6ΔNLS – Rrp47ΔC in the 
presence of Mtr4, with and without the other subunits of the nuclear exosome 
complex (Fig E3B). We first tested a double-stranded substrate with a short 3' 
overhang (10 nucleotides) that from previous work is known to be inaccessible to the 
Rrp44 exoribonuclease when in the context of Exo-9 (Bonneau et al, 2009) (Fig E3B, 
upper panel). We also tested a double-stranded substrate with a long 3' overhang (35 
nucleotides) that is accessible to the processive exoribonuclease activity of Rrp44 (Fig 
E3, lower panel). We found that the Rrp6-Rrp47 degradation properties on these 
substrates were not affected by the presence of Mtr4 (Fig E3B). Although we saw no 
significant effect of Mtr4 on the degradation of these substrates by either Rrp6 or 
Rrp44, we caution that it is possible that the helicase domain of Mtr4 might operate in 
the context of more complex RNA structures. 
 
Structure-based mutations in the Rrp6 N-terminal domain result in 5.8S RNA 
processing defects in vivo 
Loss of function rrp6 and rrp47 mutants shows strong defects in the 3' processing of 
5.8S rRNA and box C/D snoRNAs (Briggs et al, 1998; Allmang et al, 1999a; 
Mitchell et al, 2003). These mutants accumulate the 5' external transcribed spacer (5' 
ETS) fragment that is released during early processing of the pre-rRNA transcript, as 
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well as truncated fragments of U3, 5S and snR13 as a result of impaired RNA 
surveillance processes (Briggs et al, 1998; Allmang et al, 1999a; Mitchell et al, 2003). 
To address the importance of the interaction between Mtr4 and the Rrp6 – Rrp47 
heterodimer in vivo, we designed specific rrp6 and rrp47 mutants based on the 
structure of the Rrp6N – Rrp47N – Mtr4N complex and analyzed the levels and 
integrity of the above RNAs in these mutants by Northern blot hybridization. 
Mutations were generated in the N-terminal region of Rrp6 and Rrp47 to either block 
the interaction with Mtr4 in vitro (rrp6I14E,R18E, see Fig 5) or to alter other conserved 
surface residue pairs (rrp6D27R,F30R, rrp6E90R,D97R, rrp47Y55A,S59Y, rrp47L77E,L80E or 
rrp47A111Y,I115Y). 
 The rrp6I14E,R18E, rrp6D27R,F30R and rrp6E90R,D97R mutants showed an 
accumulation of the 3' extended “5.8S +30” species and a defect in the degradation of 
the 5' ETS fragment  (see Fig 7A, lanes 4-6). The phenotype was stronger for the 
rrp6D27R,F30R mutant and weaker with the rrp6I14E,R18E mutant, but reproducible (see 
also Fig E4A). In contrast, no clear effect was seen on the 3' maturation of the snR38 
snoRNA or the accumulation of degradation fragments from U3, snR13 or 5S rRNA 
in these mutants (denoted with asterisks in Fig 7A). These data are consistent with a 
partial loss of Rrp6 function in the rrp6I14E,R18E, rrp6D27R,F30R and rrp6E90R,D97R mutants. 
All rrp6 alleles complemented the temperature-sensitive growth phenotype of an 
rrp6∆ mutant (Fig 7B), were expressed comparably to the wild-type protein and had 
no effect on the expression level of Rrp47 (Fig 7C). Northern analyses of the rrp47 
mutants revealed no strong phenotypes, although a weak but reproducible 
accumulation of the 5.8S + 30 fragment was observed for the Y55A, S59Y and L77E, 
L80E mutants (Fig E4B). We concluded that mutation of conserved surface residues 
in the Rrp6 N-terminal domain, in particular D27 and F30, results in a clear defect in 
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5.8S rRNA maturation. It is currently unclear why conserved surface residues of 
Rrp6-Rrp47 that are not involved in Mtr4N binding are important for function, but it is 
possible that they are involved in additional interactions within the nuclear exosome 
complex or with the substrate ribonucleoprotein particle. 
 
Mtr4 and Rrp6 mutants show synergistic effects in vivo 
C-terminally tagged Mtr4 fusion proteins can support cell growth (Huh et al, 2003; 
Ghaemmaghami et al, 2003). Indeed, we observed no clear growth defect for an mtr4-
gfp strain when compared to an isogenic wild-type strain. Northern analyses of RNA 
isolated from the mtr4-gfp strain during growth in either minimal or rich medium did 
not show significant accumulation of the 5.8S + 30 fragment or the 3' extended forms 
of snoRNAs that are characteristic of rrp6∆ mutants (Briggs et al, 1998; Allmang et 
al, 1999a). However, the Northern analyses showed defects in the degradation of 
other structured RNAs, with a clear accumulation of the 5' ETS fragment that has 
been previously shown to accumulate upon Mtr4/Dob1 depletion (la Cruz et al, 1998) 
(see Fig 7A, lanes 7 and 8). These results indicated that the presence of the C-terminal 
GFP protein partially compromises the function of Mtr4, without causing a general 
affect on Rrp6-dependent processing or degradation pathways. We therefore 
generated an rrp6∆ allele in the haploid mtr4-gfp strain and tested for genetic 
interactions between the mtr4-gfp allele and the rrp6 mutants.  
Attempts to delete the RRP6 gene in the mtr4-gfp strain directly were 
unsuccessful, but correct integrants were isolated when the mtr4-gfp strain had been 
transformed with a URA3 plasmid encoding a functional Rrp6 fusion protein 
(Allmang et al, 1999b). Notably, deletion of the RRP6 gene was also achieved in 
mtr4-gfp strains expressing rrp6D27R,F30R and rrp6E90R,D97R variants of the Rrp6 fusion 
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protein but not the rrp6I14E,R18E mutant. To determine whether the mtr4-gfp 
rrp6I14E,R18E double mutant is synthetic lethal, wild-type and rrp6I14E,R18E mutant 
alleles were subcloned into the LEU2 plasmid pRS415, transformed into the mtr4-gfp 
rrp6∆ plasmid shuffle strain and the resulting transformants were tested for growth on 
medium containing 5-fluoro-orotic acid (5 FOA). While transformation with the wild-
type RRP6 gene gave rise to viable colonies on 5 FOA medium, no growth was 
observed for the mtr4-gfp rrp6∆ strain after transformation with a plasmid encoding 
the rrp6I14E,R18E mutant or the cloning vector (Fig 8A). We concluded that the mtr4-
gfp strain is dependent upon Rrp6 for cell growth. 
To determine whether the Rrp6/Mtr4 interaction in yeast is blocked by the 
rrp6I14E, R18E mutation, pull-downs were performed on lysates from mtr4-gfp strains 
expressing plasmid-encoded, zz epitope-tagged wild-type or mutant Rrp6 fusion 
proteins (in addition to the endogenously encoded Rrp6). Mtr4-gfp was bound to the 
wild-type zz-Rrp6 protein, but not the I14E, R18E mutant (Fig 8B, left panel). We 
then addressed whether mutation of the N-terminal region of Mtr4 also causes a block 
in the Rrp6/Mtr4 interaction in vivo. Immobilized zz-Rrp6 protein retained the wild-
type Mtr4-gfp protein, whereas binding of the mtr4-gfpF7A,F10A mutant was only 
slightly above background levels (Fig 8B, right panel). These data support the 
conclusion that the structurally defined Rrp6N - Rrp47N - Mtr4N complex forms the 
principal interaction between Rrp6 and Mtr4 in yeast. 
If the synthetic lethal phenotype observed for the mtr4-gfp rrp6I14E, R18E mutant 
(Fig 8A) is due to loss of interaction between Mtr4 and Rrp6, a strong synergistic 
effect would be predicted upon introduction of the F7A, F10A mutation in the mtr4-
gfp mutant. Indeed, both the mtr4-gfp and the mtr4F7A, F10A mutants grew comparably 
to the wild-type strain, whereas the strain expressing an Mtr4-gfp fusion protein 
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bearing the F7A, F10A mutation was nonviable (Fig 8C). We concluded that the 
strong synergistic effects observed in strains expressing a C-terminal Mtr4-gfp fusion 
protein in combination with either the Rrp6 I14E, R18E mutation (that impairs the 
interaction with the N-terminus of Mtr4) or the Mtr4 F7A,F10A mutation (that 
impairs the interaction with the N-terminal domains of Rrp6-Rrp47) is due to loss of 
binding. The very C-terminus of Mtr4 is embedded within the base of the DExH core 
of the helicase, where the 3' end of an RNA substrate is expected to emerge after 
unwinding (Jackson et al, 2010; Weir et al, 2010). Collectively, these data suggest 
that the base of Mtr4 is also engaged in interactions within the nuclear exosome 
complex and that linking the C-terminus of Mtr4 to a GFP protein weakens this 
interaction. 
Northern analyses of the viable mtr4-gfp rrp6D27R,F30R and mtr4-gfp 
rrp6E90R,D97R double mutants revealed a strong synergistic block in the degradation of 
some RNAs, including the 5’ ETS fragment and truncated fragments of U3, snR13  
and 5S rRNA (Fig 7A, lanes 9 and 10). In contrast, the defect in 5.8S rRNA 
maturation seen in the rrp6D27R,F30R or rrp6E90R,E97R mutants was not exacerbated in 
the mtr4-gfp rrp6 double mutants. This suggests that mtr4-gfp rrp6 mutants may be 
defective in RNA surveillance mechanisms, rather than 5.8S rRNA or snoRNA 
processing. 
 
Discussion 
The interaction of Rrp6 and Rrp47 is known to stabilize the individual proteins in vivo 
and to influence their function in exosome-mediated RNA processing and turnover 
pathways. The molecular basis for these effects, however, has remained unclear. Here, 
we show that the N-terminal domains of Rrp6 and Rrp47 assemble into a globular 
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heterodimer with an elaborate architecture formed by intertwined pairs of α-helices. 
The interlocked Rrp6N – Rrp47N structure explains why heterodimer formation leads 
to stabilization and to functional interdependence. In isolation, the individual proteins 
are expected to be partially unfolded and aggregated. As a 1:1 complex, they form a 
composite molecular surface for the direct recruitment of the N-terminal region of 
Mtr4, which binds via a set of evolutionarily conserved interactions. Together with 
the observation that Rrp6 and Rrp47 assemble only after they are independently 
imported into the nucleus (Feigenbutz et al, 2013b), these results rationalize how the 
cell might avoid the untimely recruitment of Mtr4 to the exosome in the cytoplasm.  
 
The Rrp6N – Rrp47N heterodimer does not undergo significant conformational 
changes upon Mtr4N binding and thus appears to function as a rather rigid platform. 
The structural analysis and in vivo data suggest that this platform also contains 
docking sites for other interaction partners whose identities remain to be explored. It 
is also likely that Rrp6, Rrp47 and Mtr4 are engaged in additional, albeit weaker, 
contacts in the context of the nuclear exosome complex. Although we did not observe 
direct interactions between Rrp6 – Rrp47 and Mpp6 and between Mtr4 and Mpp6, as 
has been reported for the human orthologues (Schilders et al, 2007), it is possible that 
the yeast proteins might engage in analogous contacts but without the high affinity 
required for detection in the in vitro reconstitution assays we used. Indeed, synthetic 
lethal mutations in S. cerevisiae support the presence of redundant interactions among 
the yeast cofactors of the nuclear exosome (Milligan et al, 2008; Garland et al, 2013 
and Fig 8A). The presence of additional weak interactions would also rationalize why 
Mtr4 would be able to carry out at least part of its functions in vivo in the absence of 
Rrp6 and Rrp47, as can be inferred from the severity of the corresponding knock-out 
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studies (la Cruz et al, 1998; Briggs et al, 1998; Mitchell et al, 2003). The emerging 
picture is that Rrp6, Rrp47, Mpp6 and Mtr4 assemble together with Exo-10 with a 
combination of high-affinity interactions and additional intermolecular contacts to 
form a functional nuclear complex (Fig 9). Understanding how the nuclear exosome 
complex is structured and how it coordinates the multiple catalytic activities of core 
components and cofactors awaits future studies.  
 
 
Materials and methods 
 
Protein purification 
S. cerevisiae Mtr4 full-length, Mtr4Δ80 and the Neurospora crassa Mtr4 orthologue 
FRH were expressed and purified according to the protocol in Weir et al 2010. Exo-9 
and Rrp44 were expressed and purified as in Makino et al 2013a. All other S. 
cerevisiae proteins purified in this study were expressed recombinantly using E. coli 
BL21-Gold (DE3) pLysS cells (Stratagene) grown in TB medium and induced 
overnight at 18°C.  Rrp6N, Rrp6ΔN and Mtr480 were expressed as His-tagged proteins. 
Rrp6N – Rrp47N, Rrp6N – Rrp47ΔC and Rrp6ΔNLS – Rrp47 complexes were co-
expressed such that the Rrp6 constructs bear an N-terminal His tag while the Rrp47 
constructs are untagged. The proteins were purified using Cobalt-based (or Nickel for 
Mtr480) affinity chromatography, followed by cleavage of the His-tag with the 
appropriate protease (Human Rhinovirus 3C protease for Rrp6N, Rrp6N – Rrp47N, 
Rrp6N – Rrp47ΔC, tobacco etch virus (TEV) protease for Mtr480, Rrp6ΔNLS – Rrp47 
and small ubiquitin-like modifier (SUMO) protease for Rrp6ΔN). Protease treated-
Rrp6ΔN was loaded on the affinity column a second time to remove uncleaved species. 
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After affinity purification, all samples (with the exception of Mtr480) were subjected 
to anion exchange chromatography (HiTrap Q HP, GE Healthcare). Rrp6ΔN and 
Rrp6ΔNLS – Rrp47 were further purified over a HiTrap Heparin Sepharose HP column 
(GE Healthcare).  
Size-exclusion chromatography (SEC) on a Superdex 200 or Superdex 75 
column (GE Healthcare) was performed as a final step of purification for all proteins. 
Rrp6N and complexes of this construct were finally purified in buffer A (20 mM Tris 
pH 7.5, 100 mM NaCl) supplemented with reducing agents. An additional 10% 
glycerol was added to the size-exclusion buffer when purifying Rrp6N and Rrp6ΔNLS –
 Rrp47.  Mtr480 was purified in buffer A supplemented with an additional 50 mM 
NaCl and 2 mM DTT. Size exclusion for Rrp6ΔN was performed in buffer B (20 mM 
MES pH 6.0, 250 mM NaCl, 10% glycerol, 2 mM DTT). Rrp6 mutants were verified 
by DNA sequencing, and purified using the protocol for the wild-type protein. Yeast 
Rrp47ΔC and Mpp6 were expressed as recombinant GST-tagged (3C- or TEV 
protease-cleavable, respectively) proteins in conditions similar to those described 
above. The proteins were purified by affinity chromatography on Glutathione 
Sepharose resin (Clontech). Tag cleavage was followed by ion-exchange 
chromatography (HiTrap SP Sepharose HP column, GE Healthcare) and SEC (in 
buffer A supplemented with 1 mM DTT and 10% glycerol) for Rrp47ΔC. Tag-cleaved 
Mpp6 was purified over a HiTrap Heparin Sepharose HP column (GE Healthcare) as 
the final step.  
 
Crystallization and structure determination 
Crystals of yeast Rrp6N – Rrp47ΔC were grown at 20°C by sitting-drop vapor 
diffusion from drops formed by equal volumes of protein (at 18 mg/ml in size 
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exclusion buffer comprising 20 mM Tris, 100 mM NaCl and 1 mM DTT) and of 
crystallization solution (1.8 M (NH4)2SO4, 125 mM NaCl and 100 mM Na-cacodylate 
pH 5.8). For heavy-atom derivatization, native Rrp6N – Rrp47ΔC crystals (grown in 
2.05 M (NH4)2SO4, 125 mM NaCl and 100 mM Na-cacodylate pH 6.4) were soaked 
for 15 minutes in crystallization solution supplemented with 1 mM Ta6Br14 prior to 
cryoprotection. Optimized Se-Met derivatized crystals were obtained in 2.0 M 
(NH4)2SO4, 200 mM NaCl and 100 mM Na-cacodylate pH 6.2. Crystals were 
cryoprotected with crystallization solution supplemented with 24% glycerol for the 
native crystals and 17.5% glycerol for the Ta soaked and Se-Met derivatized crystals 
prior to cryo-cooling and data collection.  
Yeast Rrp6N – Rrp47N complex was mixed with a 1.5-fold molar excess of 
Mtr4N (synthesized peptide (H)-MDSTDLFDVFEETPVELPTK-(NH2); D20K 
substitution for synthesis strategy and solubility reasons) and 5 mM YCl3 and 
incubated at room temperature for 10 minutes. Crystals of the Rrp6N – Rrp47N –
 Mtr4N complex were grown at 20°C by sitting-drop vapor diffusion from drops 
formed by equal volumes of complex (at 27 mg/ml in size-exclusion buffer 
comprising 20 mM Tris, 100 mM NaCl and 0.5 mM TCEP) and crystallization 
solution (12% PEG 1000, 0.1M imidazole pH 7.5 and 0.125 M calcium acetate). 
Crystals were cryoprotected in 19% PEG 1000, 0.1M imidazole pH 7.5, 0.125 M 
calcium acetate, 5 mM YCl3, 12% glycerol and supplemented with 0.5 mM Mtr4N 
peptide. Data were collected at the ID23-2 beamline of the European Synchrotron 
Radiation Facility (ESRF, Grenoble, France) and at the PXII and PXIII beamlines of 
the Swiss Light Source (SLS) (Villigen, Switzerland) and processed using XDS 
(Kabsch, 2010).  
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The Rrp6N – Rrp47ΔC structure was solved at low resolution (5.2Å) by SAD 
with SHELX (Sheldrick, 2008) and HKL2MAP (Pape & Schneider, 2004) using the 
anomalous Ta signal. Identifiable α-helices were manually placed with Coot (Emsley 
et al, 2010) and used as a starting model for SAD-MR by exploiting the anomalous Se 
signal using the program Phenix AutoSol (Terwilliger et al, 2009). After manual 
chain tracing, the model was completed with Coot and refined against the native data 
using phenix.refine (Afonine et al, 2012). The Rrp6N – Rrp47N – Mtr4N structure was 
solved by SAD-MR using Phaser (McCoy et al, 2007) with parts of the Rrp6N –
 Rrp47ΔC model as a search model and AutoSol using the anomalous signal from 
yttrium. Merohedral twinning generated by a two-fold axis perpendicular to a 
crystallographic 3-fold axis of the trigonal space group became apparent by the poor 
quality of the electron density for one of the three copies of the complex in the 
asymmetric unit. The twin law (-h,-k,l) and twinning fraction (0.5, perfect twin) was 
determined using phenix.xtriage (Adams et al, 2010). After manual tracing of the 
Mtr4N sequence, the model was completed using Coot and refined against twinned 
data using phenix.refine. Several Yttrium ions form clusters surrounded by electron 
density that likely corresponds to a negatively charged loop of Rrp6 (residues 63-73). 
 
 
Size exclusions chromatography assay 
Equimolar amounts of purified proteins as indicated (500 pmol for Fig 1C and D, 700 
pmol otherwise) were diluted in a total injection volume of 25 µl in SEC buffer A 
supplemented with 2 mM DTT. Samples were incubated for 1 hour on ice to allow 
complex formation. Increase in particle size upon complex formation was assayed by 
comparing the retention volumes in SEC on a Superdex 200 Increase 3.2/300 (GE 
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Healthcare). Composition of the SEC peak fractions were analyzed by SDS-PAGE 
and visualized by Coomassie-staining (percentage of the SDS-PAGE depended on 
protein sample size). 
 
Fluorescence anisotropy 
Fluorescence anisotropy measurements were performed with a 5'-6-carboxy-
fluorescein (6-FAM)-labeled poly(A)35 or poly(U)30 RNA at 20°C in 50 µl reactions 
on a Genios Pro (Tecan). The RNA was dissolved to a concentration of 10 nM (1 nM 
for Rrp6N, D296N – Rrp47) and incubated with Rrp6 or the Rrp6 – Rrp47 complexes at 
different concentrations in a buffer containing 20 mM Tris pH 7.5, 100 mM NaCl, 
and 1 mM DTT. The excitation and emission wavelengths were 485 nm and 535 nm, 
respectively. Each titration point was measured three times using ten reads with an 
integration time of 40 μs. The data were analyzed by nonlinear regression fitting 
using the BIOEQS software (Royer, 1993). 
 
Isothermal titration calorimetry (ITC) 
Rrp6N – Rrp47 ΔC wild-type and mutant proteins were dialyzed overnight in the same 
buffer that was used to dissolve the lyophilized Mtr4N peptide (20 mM Hepes, pH 7.5, 
100 mM NaCl, 0.5 mM TCEP). ITC experiments were carried out at 20°C with a 
iTC-200 MicroCal calorimeter (GE healthcare). The MicroCal cell was filled with 
Rrp6N – Rrp47ΔC at 50 μM concentration and stirred at 800 rpm. For each titration, 
Mtr4N was injected into the cell 20 times in 2 µl volumes per injection at the same 
intervals of time (4 min). The concentration of Mtr4N in the syringe (500 µM) was 10 
times the concentration of the protein sample in the cell. The released heat was 
obtained by integrating the calorimetric output curves and was corrected for the effect 
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of dilution by subtraction of the value of the last injection as background. As control 
for all ITC measurements, the injectant was titrated into buffer. The Kd values and 
binding ratios were calculated with the Origin (V7) software supplied with the 
calorimeter. We used the same protocol to measure the Kd of the Rrp6 and the Mtr4 
mutants. 
 
Nuclease Assay 
The exonuclease activity assay in figure 6C was carried out at 30° C in a buffer 
containing 50 mM HEPES pH 7.5, 50 mM NaCl, 5 mM magnesium diacetate, 10% 
(v/v) glycerol, 0.1% (v/v) NP40 and 1 mM DTT. The reactions contained protein at a 
final concentration of 2 nM while the concentration of RNA substrates was 200 nM. 
Substrates were verified by native gel electrophoresis. Two microliter aliquots from a 
10 µl total reaction volume were taken at indicated time points and quenched by 
addition of 14 µl loading dye consisting of 10 mM EDTA, 0.1% (w/v) bromophenol 
blue, and 0.1% (w/v) xylene cyanole FF in formamide. The 0 - time point was taken 
before adding the protein. Reaction products were boiled for 5 minutes immediately 
before being resolved on a 20% acrylamide gel containing 8 M urea and visualized by 
phosphorimaging. 
 
Plasmids and Yeast Strains 
Yeast expression plasmids encoding either an N-terminal zz fusion of Rrp6 under the 
control of the RRP4 promoter (Allmang et al, 1999b), or containing a genomic clone 
of the RRP6 gene and lacking the CEN6 element from the vector backbone 
(Feigenbutz et al, 2013a), have been reported previously. Expression of the N-
terminal zz-Rrp6 fusion protein from the RRP4 promoter is comparable to the 
 24
endogenous expression level of the C-terminal TAP-tagged protein (Stead et al, 2007). 
The RRP47 genomic clone used in this study is described in Costello et al. (Costello 
et al, 2011). The MTR4 construct pAv675 (Jackson et al, 2010) was kindly provided 
by Ambro van Hoof (University of Texas Health Science Center, Houston). The 
construct encoding mtr4-gfp was cloned in yeast by homologous recombination, using 
Hind III linearized pAv675 (after deletion of the Hind III polylinker site) and a PCR 
amplicon encompassing the mtr4-gfp::HIS3 allele. The isolated plasmid was 
confirmed by sequencing the mtr4/GFP junction along the complete length of the 
PCR product. Point mutations were introduced into the RRP6, RRP47 and MTR4 
ORFs in these constructs by site-directed mutagenesis using the Quikchange kit 
(Agilent Technologies) and validated by sequence analysis. Plasmid inserts encoding 
the N-terminal epitope-tagged wild-type RRP6 and rrp6I14E,R18E mutants were 
subcloned into pRS415 (Stratagene) for the plasmid shuffle assay. The 
rrp6∆::KANMX4 allele was amplified by PCR and integrated into the mtr4-gfp strain 
by homologous recombination after initial transformation with plasmids encoding zz-
Rrp6 fusion proteins. Correct integrants were identified by PCR amplification of 
genomic DNA.  
 The mtr4-gfp strain (Huh et al, 2003) was obtained from Invitrogen. The mtr4 
plasmid shuffle strain yAv1151 (Jackson et al, 2010) was kindly provided by Ambro 
van Hoof. Isogenic wild-type and rrp6∆ strains were obtained from Euroscarf 
(University of Frankfurt, Germany). The rrp47-zz and rrp47-zz rrp6∆ strains have 
been previously reported (Mitchell et al, 2003). Yeast strains were routinely cultured 
at 30 °C in SD selective minimal medium (2% glucose, 0.5% ammonium sulphate, 
0.17% yeast nitrogen base) supplemented with appropriate amino acids and bases, or 
in YPD medium (2% glucose, 2% peptone, 1% yeast extract). Spot growth assays 
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were performed on selective solid minimal medium or medium containing 5-fluoro-
orotic acid (5 FOA) using 10-fold serial dilutions of freshly saturated pre-cultures. 
Plates were photographed after incubation for 3 days. 
 
RNA Analyses 
Total cellular RNA was isolated from strains harvested during early log growth and 
resolved by electrophoresis through 8% polyacrylamide gels containing 50% urea. 
After transfer to Hybond N+ membranes (GE Healthcare), the RNA was hybridized 
with 5'-[32P] labeled oligonucleotide probes complementary to the ITS2 region of the 
pre-rRNA transcript (tgagaaggaaatgacgct), 5.8S rRNA (gcgttgttcatcgatgc), the 5' ETS 
region of the pre-rRNA (cgctgctcaccaatgg), snR38 
(gagaggttacctattattacccattcagacagggataactg), U3 (ttcggtttctcactctggggtac), snR13 
(caccgttactgatttggc), 5S (ctactcggtcaggctc), SCR1 (aaggacccagaactaccttg) and U6 
(atctctgtattgtttcaaattgaccaa). Hybridized blots were placed under phosphor storage 
screens and the data was captured using a Personal Molecular Imager (BioRad). 
Nonsaturated images were adjusted for signal level and window using ImageJ (NIH, 
USA). RNA hybridization signals were quantified using ImageJ and normalized to the 
expression level of 5S rRNA.  
 
Protein Analyses 
For protein expression analyses, total cellular protein was prepared by alkaline/SDS 
lysis followed by TCA precipitation. Extracts were resolved by SDS/PAGE, 
transferred to Hybond C extra membranes (GE Healthcare) and incubated with a 
rabbit anti-Rrp6 antiserum (Mitchell et al, 2003) or mouse anti-Pgk1 (clone 22C5D8, 
Life Technologies) primary antibody, followed by either goat anti-rabbit (A4914, 
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Sigma) or goat anti-mouse (1706516, BioRad) HRP-conjugated secondary antibodies. 
The Mtr4-gfp fusion protein was detected using the anti-GFP antibody. The Rrp47-zz 
fusion protein was detected directly using the PAP antibody conjugate (P1291, 
Sigma). ECL images were captured using a G:Box iChemi XL system (Syngene) and 
adjusted for the signal level and window using ImageJ. 
For the pull-down experiments, yeast were lysed in 50 mM HEPES pH 7.4, 50 
mM KCl, 5 mM MgCl2, 10 % glycerol, 1 mM PMSF. Lysates were clarified by 
centrifugation at 13,000 g for 30 minutes, normalized for A280 units, and passed 
through ~ 200 μl IgG sepharose fast flow beads (GE Healthcare). The beads were 
washed 5 times with 1 ml wash buffer (50 mM HEPES pH 7.4, 100 mM KCl, 5 mM 
MgCl2, 0.1% NP-40, 1 mM DTT) and the retained material was eluted with 0.5 M 
acetic acid. Eluates were resolved through 10 % SDS-PAGE gels and analyzed by 
western blotting, as described above.  
 
Data deposition 
The coordinates and structure factors have been deposited in the Protein Data Bank 
with accession codes xxx for the Rrp6N – Rrp47ΔC structure and yyy for the Rrp6N –
 Rrp47N – Mtr4N structure. 
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Figure legends 
 
Figure 1 
Direct interactions of the nuclear cofactors of the yeast exosome 
(A) Schematic representation of the domain arrangement of the nuclear exosome 
cofactors from S. cerevisiae used in this study. Gray-filled rectangles denote domains 
whose structures are known from previous studies: the central region of Rrp6 with the 
exonuclease (Exo) and HRDC domains (Midtgaard et al, 2006), the exosome-binding 
domain in the C-terminal region of Rrp6 (Makino et al, 2013a) and the entire helicase 
region of Mtr4 (Jackson et al, 2010; Weir et al, 2010). Colored rectangles highlight 
the N-terminal domains of Rrp6, Rrp47 and Mtr4 visualized in the structure of the 
ternary complex reported here. Truncation mutants engineered for the biochemical 
and structural analysis are indicated. 
(B-G) Size-exclusion chromatography assay to assess formation of protein complexes. 
Purified samples (as indicated) were incubated and co-injected on an analytical size-
exclusion column (Superdex 200 Increase 3.2/300, GE Healthcare, exclusion volume 
0.8 ml). On the left are the overlays of the chromatograms (rel. AU and Vr denote 
relative absorbance and retention volume of the proteins, respectively). On the right, 
are the Coomassie-stained SDS-PAGE gels with samples from the corresponding 
peak fractions. The detailed analysis of the chromatography profiles is shown in Table 
E1.  
 
Figure 2 
Structure of the yeast Rrp6N – Rrp47N – Mtr4N ternary complex 
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(A) Structure of the Rrp6N – Rrp47ΔC binary complex shown in cartoon representation 
with Rrp6 in red and Rrp47 in orange. The N- and C-terminal residues are indicated. 
This and all other cartoon drawings were generated with PyMOL (http:// 
www.pymol.org/). 
(B) Structure of the Rrp6N – Rrp47N – Mtr4N ternary complex shown in cartoon 
representation in two orientations related by a 90° rotation about the horizontal axis. 
The orientation of the ternary complex in the left panel is the same as that of the 
binary complex in panel A. The secondary structure elements are labeled. A 
disordered region in the structure is indicated as a dotted line. The electron density for 
Mtr4N (Fo-Fc, contoured at 2.0 σ in Pymol) and the model built into this density 
(blue) are shown. 
(C) Superposition of the atomic models of Rrp6N and Rrp47N, showing the similarity 
of their secondary structure elements (labeled as in panel B). 
(D) Topological diagram of the secondary structure elements of Rrp6N and Rrp47N. 
The left and right panels correspond to the views of the structure in the left and right 
panels of Fig 2B, respectively. 
 
Figure 3 
Rrp6N and Rrp47N form a highly intertwined structural module 
(A) Intermolecular contacts between the α1 and 2 helices (from both Rrp6N and 
Rrp47N), which form the center of the helical bundle. On the right is a zoom-in with a 
subset of the extensive Van der Waals interactions shown on the left. 
(B) Intermolecular contacts between helices α2 and α3 (from both Rrp6N and 
Rrp47N), which are at the side of the bundle. A zoom in view of part of the 
interactions is shown on the right. 
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Figure 4 
Structure-based sequence alignments of Rrp6N, Rrp47N and Mtr4N 
The alignments of Rrp6 (A), Rrp47 (B) and Mtr4 (C) include orthologues from the 
representative species S. cerevisiae (S.c.), Neurospora crassa (N.c.), H. sapiens (H.s.), 
D. melanogaster (D.m.) and D. rerio (D.r.), based on a comprehensive alignment. The 
secondary structure elements are shown above the sequences. Conserved residues are 
highlighted in color. Colored circles above the sequences identify residues involved in 
the interaction with Rrp6 (red circles), with Rrp47 (orange circles) and with Mtr4 
(blue circles). Circles of two colors indicate residues involved in interactions with two 
partners in the ternary complex. Residues targeted for mutagenesis are highlighted 
with a black square. 
 
Figure 5 
Mtr4N binds at an evolutionary conserved surface groove of Rrp6N-Rrp47N 
(A) Surface representation of Rrp6N – Rrp47N colored according to sequence 
conservation (corresponding to the comprehensive alignments used for Fig 4). The 
complex is shown in two orientations related by a 180° rotation about the vertical axis. 
The concave surface of Rrp6N – Rrp47N is viewed on the left (with an orientation 
corresponding to that in Fig 2B, left panel) where Mtr4 is shown with the helix in 
cartoon representation. Peripheral patches of conserved residues of Rrp6 not involved 
in the interaction with Mtr4 are also indicated. 
(B) Close-up view of the interactions of Mtr4N with Rrp6N and Rrp47N. Interacting 
residues are shown in stick representation and labeled. 
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(C) Isothermal titration calorimetry experiments (ITC) of the Mtr4N peptide with 
Rrp6 – Rrp47. The MicroCal cell was filled with Rrp6N – Rrp47ΔC complex at 50 μM 
and the Mtr4 peptide was injected at 500 μM concentration consecutively in 2 μl 
volumes. The left panel shows binding with the proteins used in the structure 
determination. Shown in the inset are the number of calculated binding sites (N), and 
the dissociation constant (Kd), as calculated with the program Origin. The middle and 
right panels show the corresponding ITC experiments with structure-based mutations. 
A Coomassie stained gel with the wild-type and mutant complexes used in these 
experiments is shown on the right. 
 
Figure 6 
Impact of Rrp6N-Rrp47N on ribonuclease activity 
(A) Surface representation of Rrp6N – Rrp47N colored according to electrostatic 
potential (blue for electropositive and red for electronegative). Mtr4N is shown in gray, 
with negatively charged residues in a stick representation. The molecule is viewed in 
the same orientations as in Fig 5A.  
(B) Quantitative measurements of RNA-binding affinities in solution by fluorescence 
anisotropy using fluorescein-labeled homopolymeric substrates. The data were fitted 
to a binding equation describing a single-site binding model to obtain the dissociation 
constants (Kd). The best fit was plotted as a solid line. The Kds and their 
corresponding errors are the mean and standard deviation of a minimum of 3 
independent experiments and are compiled in the table (top panel).  
(C) Nuclease activity of the indicated Rrp6 and Rrp6 – Rrp47 constructs towards 
single stranded RNAs and duplex RNAs with 3' overhangs. Substrates were designed 
to have a 17 base pair GC-rich duplex (ds17), corresponding to the 3' end of tRNATyr 
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(Lorentzen et al, 2008; Vincent & Deutscher, 2006), and a 3' overhang of 10 adenine 
nucleotides (A10). The RNAs were 5' end labeled with [γ32P]ATP and the reaction 
products were resolved on 20% denaturing PAGE and visualized with a 
phosphorimager. A Coomassie stained gel with the wild-type and nuclease deficient 
mutant proteins used in the RNase activity and RNA affinity assays (B) is shown on 
the right. 
 
Figure 7 
Structure-based mutations in the Rrp6 N-terminal domain result in 5.8S RNA 
processing defects in vivo  
(A) Northern blot analyses of RNA from rrp6, mtr4-gfp and mtr4-gfp rrp6 double 
mutants. Strains were grown in selective minimal medium, unless indicated otherwise. 
Consecutive hybridizations of a single blot are shown; panels shown for lanes 1-6 and 
7-11 are juxtaposed from a single image. The major RNAs detected by each probe are 
indicated on the right. Asterisks indicate truncated RNA fragments of U3, snR13 and 
5S. The amount of “5.8S+30” RNA, the 5’ ETS fragment and the major U3 and 5S 
degradation fragments in each mutant (indicated beneath the appropriate panel) is 
expressed relative to the rrp47-zz strain in lanes 1-6 and to the mtr4-gfp strain during 
growth in YPD in lanes 7-11. 
(B) Spot growth assays of rrp6 mutants. Serial dilutions of pre-cultures were spotted 
onto selective minimal medium plates and incubated at 30 °C or 37 °C. The plates 
were photographed after three days. 
(C) Western analyses of rrp6 mutants. (Upper panels) Expression levels of Rrp6 and 
the Rrp47-zz fusion protein in the rrp6 mutants. (Lower panels) Mtr4–gfp fusion 
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protein expression levels in the mtr4-gfp rrp6 double mutants. Pgk1 levels were 
analyzed as a loading control in each case. 
 
Figure 8  
Disruption of the Rrp6/Mtr4 interaction in yeast blocks growth of mtr4-gfp 
strains 
(A) Plasmid shuffle assay on an mtr4-gfp rrp6∆ strain expressing zz-Rrp6. 
Transformants harboring LEU2 plasmids encoding wild-type zz-Rrp6, the I14E, R18E 
variant or the vector alone were cultured in selective medium and then spotted onto 
medium lacking leucine or containing 5 FOA. Plates were incubated at 30 °C and 
photographed after three days. 
(B) Pull-down assays of zz-Rrp6 with Mtr4-gfp. Left Panels Pull-downs of zz-Rrp6 in 
an mtr4-gfp strain harboring the vector (lane 1), expressing zz-tagged wild-type Rrp6 
(lane 2) or the I14E,R18E variant (lane 3). The amount of Mtr4-gfp associated with 
Rrp6 is expressed relative to the negative control and is normalized to the Rrp6 levels 
in the eluates. The mean values of assays on two independent biological replicates are 
shown. Error bars indicate the experimentally observed range. Right Panels Pull-
downs of zz-Rrp6 in a wild-type strain expressing the Mtr4-gfp fusion protein or the 
F7A,F10A mutant. A wild-type strain was transformed with plasmids expressing 
either non-tagged or zz-tagged Rrp6 and Mtr4-gfp or the F7A,F10A mutant and 
analyzed by western, as above. 
 (C) mtr4 plasmid shuffle assay. An mtr4∆ mutant strain harboring a URA3 plasmid 
containing the wild-type MTR4 gene was transformed with LEU2 plasmids encoding 
mtr4-gfp, mtr4F7,F10A or mtr4-gfpF7A,F10A mutants, the wild-type MTR4 gene or the 
vector. Strains were grown up in selective medium and then spotted onto medium 
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lacking leucine (SD-Leu) or containing 5 FOA. The plates were incubated at 30°C 
and photographed after 3 days. 
 
Figure 9 
Model of the nuclear exosome complex 
The schematic representation shows the architecture of the yeast nuclear exosome 
based on current structural and biochemical information. The exosome core (Exo-10) 
is depicted with the RNase PH-like subunits in gray, the S1/KH subunits in orange 
and Rrp44 in pink (based on the structure reported in Makino et al, 2013a). RNA is 
shown in black, threading through the internal channel and reaching the 
exoribonuclease site of Rrp44 (highlighted with a circle). The endonuclease site in the 
PIN domain of Rrp44 is also highlighted with a circle. Rrp6 is shown in red, with the 
exoribonuclease site highlighted as a circle. The exoribonuclease of Rrp6, depicted 
based on Midtgaard et al, 2006, is positioned near the exosome-binding domain of 
Rrp6, as determined by Makino et  al, 2013a. Rrp47 is in gray while Mtr4 is in blue. 
The channel in the helicase core and the insertion domain of Mtr4 are indicated in the 
model (according to the structures reported by Jackson et al, 2010; Weir et al, 2010). 
The N-terminus of Mtr4 binds at the interface between Rrp6 and Rrp47. The N-
terminal interaction regions of Rrp6, Rrp47 and Mtr4 are denoted by N. Mpp6 is 
shown tentatively at the top of Exo-10, as its binding is not dependent on Rrp44.  
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Table I. Crystallographic Statistics 
Data set Rrp6N-Rrp47ΔC native 
Rrp6N-Rrp47ΔC 
Ta6Br14 
Rrp6N-Rrp47ΔC 
Se-Met 
Rrp6N-Rrp47N-Mtr4N 
native 
Data collection     
Space group P 41 2 2 P 41 2 2 P 41 2 2 P 3 1 2 
Unit cell (a, b, c in Å) 98.5, 98.5, 208.0 98.6, 98.6, 205.3 97.9, 97.9, 207.7 142.7, 142.7, 63.5 
Wavelength (Å) 0.873 1.255 0.979 1.000 
Resolution range (Å) 69.62 – 2.64 (2.73 – 2.64) 
88.85 – 5.19 
(5.80 – 5.19) 
48.96 – 3.59 
(3.94 – 3.59) 
47.42 – 2.40 
(2.48  – 2.40) 
Unique reflections 30965 (2987) 4311 (1169) 12424 (2850) 28898 (2781) 
Completeness (%) 99.8 (98.4) 99.6 (98.6) 99.6 (98.5) 99.6 (96.3) 
Multiplicity 10.5 (10.2) 11.7 (11.6) 41.8 (42.9) 17.3 (17.1) 
Mean I/ σ (I) 21.50 (2.94) 14.7 (3.5) 20.3 (8.6) 26.64 (1.68) 
R-merge 0.098 (0.857) 0.140 (0.837) 0.278 (0.644) 0.092 (1.989) 
CC1/2 0.999 (0.813) 0.998 (0.879) 0.998 (0.972) 1.000 (0.603) 
Refinement     
R-work (%) 20.74   19.42 
R-free (%) 23.81   23.86 
Rmsd bonds (Å) 0.003   0.010 
Rmsd angles (°) 0.62   1.40 
Average B-factor 60.30   71.7 
Ramachandran 
favored (%) 99   99 
Ramachandran  
outliers (%) 0.18   0.36 
Values in parentheses correspond to the highest-resolution shell. 
 
 
ARrp6 Rrp47
Mtr4
184Rrp6 binding
domain
5 102
1
Rrp47?C
133
Rrp47N
103
7331 Exo
domain
HRDC
domain
Rrp47 binding
domain
129 398 439 5165 106 NLS
Rrp6?NLS
693
Rrp6N
111
1 1073
Mtr480
80
RecA-1 RecA-2 SK insert helical bundle
81 618 873322 580 912
Mtr4???
81
532 619
Exosome
binding
Mtr4N
20
Rrp6?N
693122
B C
0
0.2
0.4
0.6
0.8
1
0.9 1.1 1.3 1.5
M
116
66
45
35
25
18
14
[kDa]
Mtr4
Rrp6?NLS
Rrp47
Mpp6
21 5432 1 4
5
3
Mtr4 + Mpp6
Rrp6?NLS/Rrp47
Rrp6?NLS/Rrp47
+ Mtr4 + Mpp6
rel. AU
Vr (ml) 0.9 1.1 1.3 1.5
0
0.2
0.4
0.6
0.8
1 1 3
4
25
6
116
66
45
35
25
18
14
[kDa] 1 2 3 4 5 6M
Mtr4
Rrp6?NLS
Rrp47
Rrp6?N
Exo-9
Exo-9 + Rrp6?N
+ Mtr4
Exo-9
+ Rrp6?NLS/Rrp47
Exo-9 + Rrp6?NLS/
Rrp47 + Mtr4
Exo-9
Mtr4
Vr (ml)
rel. AU
D E
0
0.2
0.4
0.6
0.8
1
0.9 1.1 1.3 1.5
116
66
45
35
25
18
14
[kDa]261 4
3
5
1 2 3 4 5 6M
Mtr4
Rrp44
Rrp47
Rrp6?NLS
Exo-9
Mpp6
Exo-9 + Mtr4 + Mpp6
Exo-9 + Rrp6?NLS/Rrp47 
+ Mtr4 + Mpp6
Exo-9 + Rrp44 + Rrp6?NLS/
Rrp47 + Mtr4 + Mpp6
Exo-9
Mtr4
rel. AU
Vr (ml)
0
0.2
0.4
0.6
0.8
1
0.9 1.1 1.3 1.5
M
116
66
45
35
25
18
14
[kDa]
Rrp47?C
Rrp6N
1 2 4 1 2 4 5
5
3
3
Mtr4???
Mtr4
Rrp6N/Rrp47?C
Mtr4??? + 
Rrp6N/Rrp47?C
Mtr4
Mtr4 + 
Rrp6N/Rrp47?C
rel. AU
Vr (ml)
F G
0
0.2
0.4
0.6
0.8
1
1.3 1.5 1.7
M
116
66
45
35
25
18
14
[kDa]
Mtr480
Rrp47?C
Rrp6N
1 2 31 2 3
Mtr480
Rrp6N/Rrp47?C
Mtr480 + 
Rrp6N/Rrp47?C
rel. AU
Vr (ml)
0
0.2
0.4
0.6
0.8
1
0.9 1.1 1.3 1.5 1.7
M
116
66
45
35
25
18
14
[kDa] 5421 3
5
3
2
1
4
Rrp47?C
Rrp6N
Mtr4
Mtr4 + Rrp6N
Rrp6N/Rrp47?C
Mtr4 + Rrp47?C
rel. AU
Vr (ml)
AC
90°
100
1
4
104
4
17
Rrp6
Rrp47
D
Rrp47
Rrp6
??
??
????
?? ??
Rrp47
N
N
Rrp6
??
?short
??
??
?? ?? ??
?short
??
C
C
N
N
?? ????
?short
????
?short
???
106
5
5
Rrp6
Rrp47
Mtr4 Mtr4
B
??
?short
?? ??
?? ??
??
?short
17
104
4 100
14
Rrp6
Rrp47
?short
??
??
??
??
??
?short
??
90°
ARrp6
Rrp47

short

short







B
Rrp6
Rrp47
     LF  F                             D  DV EE PMDST T.. VELPTDSNGEKNADTN......V
     LF  F                             D  EV EE PMD.. Q.. RAQKKRKA..S...........P
     LF  F                             DE  V E S..G S GD TTAAGTKKDKEKDKGKWKGPPGSA.
     LF  F                             EE  D  DE T..I C V P...SVPPPALNQEEKPSGSS....
     LF  F                             DD  V DE Q G..G S E A SSKKA.APKSAANAGKTPDKAG.
                                                      Y             G ME I V F LD L I L S S E L D L L A VLSSL FA MKV  VDIEK KPY RS SKA E KPE EK T K LD Q LLLS ERAK E INRY M N L
                                                      Y             G MD DI L LD LE AL VL DV K L LD AKL VM  AI SI F LRLN V.VP TPS EKLNVD Q A KP GD.VG SS . PL K Y VT E L SS
                                                      Y             G D EI L F NSI VD ML MMSVS ELL K LD LEQAKVDLV A LNSMFWVYL Q VE YPV HEY SA E GA E KT RN Q . P S T AT
                                                      Y             G L M L F SSIE LE AL LQ A L EQIKLD V L STLFFIYLKLQ REDEN QHI KT Y L ADTEK A ... ERT. NTN SYL N E
                                                      Y             G D EI L F SSL V MV LVSVS D L K LD LEQAKLDLM A ALNSMFWMYL Q VE YPT EDN ND D SS QN QT RS R L . P S VT
          L R                             A                           PI E  VKSYM KAK R AE E  I NVL I RSKDMS. LG K D QYDN ITK.SNEKSQ Q K KNI S DGNKNQ....FEPS. S
          L R                             A                           KEH I TE  VRQY KI I V KEA RFIRS L D I KDA A F T FE QN ENPPQ.ERE.Q.T N A D A DEAI.KQKLTEL. A E
          L R                             A                           KEHPV QE  IR YM RVK ITDK A KLDR A RFVKNAL E A KNP K E V N E KK.. ..G. G S W PKSK.NAS..K.V N G
          L R                             A                           H V D  R L R K IND A RLD A RFI KQDASN A MH R T DL A D K ALA.. ..P. MP K AAGTHTRFVDMNGVM...VSE
          L R                             A                           KDHPI QE  IRTYM KVK ITDR A HIDKEA RFVRNAL D QNP K E N E RK.. ..A. S W ADDK.KRK.DK.TEHQ
MT.S ...NP..DV  SR  N V    S A ..Q V     LDR   KD K KA    D   E  L IDE    E         LL  VI V RAAS L S   D DFYKN   GFS  L S  DKLA MAN II S   
G   D  S      L   LVA TR AN I S  ED  F RT  P     LDNS  RLL LAN LL S    S.L FK LR..ES QAA   T  T  S A ..  LQ Q  VN TVGGQ    SG   S   G  K TAN
G   DADSF     AL  VVAVTKA   LPQ GDE DFYRSF PGFQ   ETQ DRLL  MS VM  H   F.P     V..KF  GS       SGG   F   Y      .    AFC   G    QC  R  QY GC
    DVE F         AIAATKAAN  PQ G     Y SY PGY   ME    RVV LI  VL SK  A.SE   A TNK..GFKN         AF  . TARAL L  .   ARV  DLTQ   A  GN  H  DI
G   DVDTF      L  VV ATKA   LPS GDE D YRSF   FQ    SQ DRLL  MS IM  H   F.K     V..KHG GA  S    SAA   A   F L    .SS  QFCA  G    HC  Q  QH GC
C
A
B
S.c. Rrp47    1
N.c. Rrp47    1
H.s. Rrp47    8
D.m. Rrp47   22
D.r. Rrp47    8
S.c. Rrp47   71
N.c. Rrp47   68
H.s. Rrp47   77
D.m. Rrp47   88
D.r. Rrp47   77
S.c. Rrp47
 .  .S.c. Rrp47
??1 ??short ??2
??3
 
S.c. Mtr4    1
N.c. Mtr4    1
H.s. Mtr4    6
D.m. Mtr4    3
D.r. Mtr4    6
S.c. Mtr4
? 1
 
S.c. Rrp6    1
N.c. Rrp6    3
H.s. Rrp6   28
D.m. Rrp6   27
D.r. Rrp6   32
S.c. Rrp6   63
N.c. Rrp6   68
H.s. Rrp6   94
D.m. Rrp6   92
D.r. Rrp6   98
 S.c. Rrp6
S.c. Rrp6
? 1 ??short ??2
??3
 
                          D   E     LD                               H E DI D W I  LL   LN A S SHESF LK...EE S L NNFGN M N MSDHS K C IN K RGSD
                          D   E     LD                               T K DVD W IVDV  LL KA   E TGL K PL GQ VGALEDAD IQ RN I S DTC Y I RKDAPT
                          D   E     LD                               RS IKDR ELED FDLLVDAN VIL RV   EASGV KNQQ VLPN SKV..T K GIL N P
                          D   E     LD                               K IK R EE FEMV E N VL  RI   GL RNTQ VVGD K ......QP Q Q C F TTN IKG R Q E
                          D   E     LD                               RS MRDR LED FDLVVDAN AIL KV   EASGV RSQQ VMPH NKL..TG R GIL S P
 
CA B
Rrp6N-Rrp47C + Mtr4N
Molar Ratio
Time (min)
μc
al
/s
ec
kc
al
/m
ol
 o
f I
nje
cta
nt
0 10 20 30 40 50 60 70 80 900.05
0.00
-0.05
-0.10
-0.15
-0.20
-0.25
0.00
-1.00
-2.00
-3.00
0.0 0.5 1.0 1.5 2.0 2.5
Kd 
N 1.08 sites
1.3 μM
Rrp6N-Rrp47C + Mtr4N, F7A, F10A
0.0 0.5 1.0 1.5 2.0 2.5
0 10 20 30 40 50 60 70 80 90
Molar Ratio
Time (min)
μc
al
/s
ec
kc
al
/m
ol
 o
f I
nje
cta
nt
0.05
0.00
-0.05
-0.10
-0.15
-0.20
-0.25
0.00
-1.00
-2.00
-3.00
Rrp6N, I14E, R18E-Rrp47C + Mtr4N
Molar Ratio
Time (min)
μc
al
/s
ec
kc
al
/m
ol
 o
f I
nje
cta
nt
0 10 20 30 40 50 60 70 80 900.05
0.00
-0.05
-0.10
-0.15
-0.20
-0.25
0.00
-1.00
-2.00
-3.00
0.0 0.5 1.0 1.5 2.0 2.5
M
116
66
45
35
25
18
14
[kDa]
Rrp6N
Rrp47
C
R
rp
6 N
/R
rp
47

C
R
rp
6 N
, I
14
E,
 R
18
E/R
rp
47

C
180°
low highconservation
Glu90
Asp97
Phe30
Asp27
R18
L10
I14
V17
F7
F10
E12
V9
L6
D5
F62
Y55 L80
K84
L77
Rrp6 Mtr4
Rrp47
M87
Y10
K6
L17
V15
E16
Q26
CA
-4.0 kT/e +4.0 kT/e
180°
B
Rrp6N
Rrp47?C
Rrp6122-518, D296N Rrp61-518, D296N
Rrp47?C
RNA affinity (Kd [μM])
RNA oligo
polyA 35mer
polyU 30mer
5.1 ± 0.3
2.8 ± 0.8
1.6 ± 0.4
1.9 ± 0.4
not detectable (>550)
not detectable (>550)
polyA 35mer
0.01 0.1 1 10 100
0.0
0.2
0.4
0.6
0.8
1.0
R
el
at
iv
e 
flu
or
es
ce
nc
e
Concentration (μM)
 Rrp6122-518
 Rrp61-518, D296N/Rrp47?C
polyU 30mer
0.01 0.1 1 10 100
0.0
0.2
0.4
0.6
0.8
1.0
R
el
at
iv
e 
flu
or
es
ce
nc
e
Concentration (μM)
 Rrp6122-518
 Rrp61-518, D296N/Rrp47?C
Rrp6N
Rrp47?C
0 205 90
ss17A10
*
ds17A10
*
0 205 90 0 205 90 0 205 90 0 205 90
ss17A10
*
ds17A10
*
ss17A10
*
Rrp6122-518 Rrp61-518
Rrp47?C
Time (min)
M
116
66
45
35
25
18
14
[kDa]
Rr
p6 N
-R
rp
47 ?
C
Rr
p6 1
22
-5
18
Rr
p6 1
-5
18
-R
rp
47 ?
C
w
t
D
29
6N
w
t
w
t
D
29
6N
Rrp6122-518
Rrp61-518
Rrp47?C
Rrp6N
AYP
D
SD zz
-rr
p6
	

rrp
47
-zz
ve
cto
r
RR
P6
mtr4-gfp
	

mtr4-gfp
7S
5.8S+30
5.8S+30
5.8S
5’ ETS
snR38
U3
U3*
snR13
snR13*
5S
5S*
SCR1
1 2 3 4 5 6 7 8 119 10
rrp
6 I1
4E
,R1
8E
rrp
6 D
27
R,F
30
R
rrp
6 E9
0R
,D9
7R
zz
-rr
p6
 
 
 
 
 
 
D2
7R
,F3
0R
zz
-rr
p6
 
 
 
 
 
 
E9
0R
,D9
7R
1 2 3 4 5 6 7 8 9 10 11
1.0 1.0 1.02.7 0.9 1.4
1.0 1.02.3 0.8 0.9 0.8
1.0 2.9 0.9 1.9 3.8 2.9
1.0 8.5 0.9 1.6 5.8 2.2 1.0 1.3 11.2 6.2 1.7
1.0 1.9 7.8 7.3 3.0
1.0 1.6 6.3 6.7 1.7
1.0 1.1 8.5 8.4 2.6
B
RRP6
vector
RRP6



	

 rrp6I14E,R18E
D27A,F30Arrp6
E90R,D97Rrrp6
D27R,F30Rrrp6
30°C
37°C
RRP6
vector
RRP6



	

 rrp6I14E,R18E
D27A,F30Arrp6
E90R,D97Rrrp6
D27R,F30Rrrp6
C
Rrp47-zz
Pgk1
rrp
47
-zz
	

RR
P6
ve
cto
r
rrp
6 I1
4E
,R1
8E
rrp
6 D
27
A,F
30
A
rrp
6 E9
0R
,D9
7R
rrp
6 D
27
R,F
30
R
Rrp6
Mtr4-gfp
Pgk1
	

zz
-rr
p6
zz
-rr
p6 D
27
A,F
30
A
zz
-rr
p6 D
27
R,F
30
R
zz
-rr
p6 E
90
R,D
97
R
mtr4-gfp
YP
D
SD
m
tr4
-gf
p
2
4
6
8
10
12
0
B
1 2 3
I14
E R
18
E
zz
-rr
p6
m
tr4
-gf
p
zz
-rr
p6
m
tr4
-gf
p
ve
cto
r
0
2
4
6
Mtr4-gfp
RR
P6
zz-Rrp6
4 5 6
m
tr4
-gf
p
zz
-rr
p6
m
tr4
-gf
p
zz
-rr
p6
m
tr4
-gf
p F7
A F
10
A
vector
MTR4
mtr4-gfp
mtr4
mtr4-gfp
SD - Leu 5 FOA





 
+
 
pR
S4
16
/M
TR
4
F7A,F10A
C
A
m
tr4
-g
fp
 





 
+
 
pR
S4
16
/z
z-
rr
p6
zz-rrp6
vector
SD - Leu 5 FOA
zz-rrp6I14E,R18E
M
tr4
 b
in
di
ng
,
a
rb
itr
ar
y 
un
its

